Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARE Study
PACTR202312652733486Phase 4Not yet recruiting
- Sponsor
- Population Council
- Start
- Mar 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Phase 4, open-label trial of segesterone in None (2 arms), sponsored by Population Council. Primary endpoint: Satisfaction with contraceptive method. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
segesterone
Beyond the preview
Go deeper on PACTR202312652733486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202312652733486.